Abstract
Please check the hierarchy of the section headings and confirm if correct.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
“Sponsor” is the term FDA uses for any person, company, or institution that sends a submission to the FDA.
- 2.
The CDRH Organizational chart is available on the FDA website.
- 3.
Contact DICE by email: DICE@fda.hhs.gov or by phone at 1 (800) 638-2041 or (301) 796-7100.
References
Association for the Advancement of Medical Instrumnetation (AAMI), FDA focus on postmarket benefit–risk for medical devices. 2016. Available from: http://www.aami.org/productspublications/articledetail.aspx?ItemNumber=3707. Cited 4 Aug 2016.
Di Prima M, et al. Additively manufactured medical products – the FDA perspective. 3D Print Med. 2016;2(1)
FDA/CDRH. Food and Drug Administration Modernization Act (FDAMA) of 1997a. Available from: http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDAMA/.
FDA/CDRH. Design control guidance for medical device manufacturers. 1997b. Available from: http://www.fda.gov/downloads/MedicalDevices/.../ucm070642.pdf. 11 Mar 1997
FDA/CDRH. Medical device premarket approval: master files. 2002. Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketApprovalPMA/ucm142714.htm.
FDA/CDRH. FDA and industry procedures for section 513(g) requests for information under the federal food, drug, and cosmetic act. 2012a. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM209851.pdf. 6 Apr 2012.
FDA/CDRH. Factors to consider when making benefit-risk determinations in medical device premarket approvals and de novo classifications. 2012b. Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm267829.htm. 28 Mar 2012.
FDA/CDRH. Investigational device exemptions (IDEs) for Early feasibility medical device clinical studies, including certain first in human (FIH) studies. 2013a. Available from: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm279103.pdf. 1 Oct 2013.
FDA/CDRH. Humanitarian Use Device (HUD) Designations. 2013b. Available from: https://www.fda.gov/downloads/ForIndustry/DevelopingProductsforRareDiseasesConditions/DesignatingHumanitarianUseDevicesHUDS/LegislationRelatingtoHUDsHDEs/UCM336515.pdf. 24 Jan 2013.
FDA/CDRH. Evaluating substantial equivalence in premarket notifications [510(k)]. 2014a. Available from: http://www.fda.gov/downloads/MedicalDevices/…/UCM284443.pdf. 28 Jul 2014.
FDA/CDRH. Requests for feedback on medical device submissions: the pre-submission program and meetings with Food and Drug Administration staff. Available from: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm311176.pdf. 18 Feb 2014b.
FDA/CDRH. Technical considerations for additive manufactured devices. 2016a. Available from: https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddevgen/documents/document/ucm499809.pdf 10 May 2016.
FDA/CDRH. Food and Drug Administration Safety and Innovation Act (FDASIA). 2016b. Available from: http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm20027187.htm.
FDA/CDRH. Use of International Standard ISO 10993–1, Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process. 2016c. Available from: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm348890.pdf. 16 June 2016.
FDA/CDRH. Applying human factors and usability engineering to medical devices 2016d. https://www.fda.gov/downloads/MedicalDevices/…/UCM259760.pdf 3 Feb 2016.
FDA/CDRH. Evaluation of automatic class III designation (de novo) summaries. 2017. Available from: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHTransparency/ucm232269.htm.
Hunter NL, Califf RM. FDA’s patient preference initiative: the need for evolving tools and policies, in FDA voice. 2015. September 25, 2015. Available from: https://blogs.fda.gov/fdavoice/index.php/tag/patient-preference-initiative.
LaFrance A. To help solve challenging cardiac problems, doctors at Children’s press ‘print’. The Washington Post. 2013.
Morris J. Q&A: How Mayo is integrating 3D printing into the operating room. In: Schaust S, editor. Twin cities business. 2016. http://tcbmag.com/News/Recent-News/2016/April/Q-A-How-Mayo-Is-Integrating-3D-Printing-Into-The-O.
Mukherjee T, et al. Printability of alloys for additive manufacturing. Sci Rep. 2016;6:19717.
Phoenix Children’s Heart Center. Cardiac 3D print lab. Available from: http://heart.phoenixchildrens.org/cardiac-3d-print-lab. 2017.
Tague NR. The quality toolbox, vol. 2. Milwaukee: ASQ Quality Press; 2005. p. 584.
Tartal J. Quality system regulation overview. FDA Small Business Regulatory Education for Industry (REdI). 2014. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/UCM408002.pdf. 17 June 2014.
US Department of Health and Human Services. The HIPAA privacy rule. 2005. Available from: http://www.hhs.gov/hipaa/for-professionals/privacy/.
Acknowledgments
We would like to thank Matthew Di Prima, Jennifer Kelly, David Hwang, and Laura Ricles of the CDRH Additive Manufacturing Working Group for their help in compiling this information and their continuing efforts in 3D printing regulation, research, and public education.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Coburn, J.C., Grant, G.T. (2017). FDA Regulatory Pathways and Technical Considerations for the 3D Printing of Medical Models and Devices. In: Rybicki, F., Grant, G. (eds) 3D Printing in Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-61924-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-61924-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61922-4
Online ISBN: 978-3-319-61924-8
eBook Packages: MedicineMedicine (R0)